Reflux study after esophageal cancer surgery
Part of Cancer, Digestive system clinical trials.
This study is for people who have had surgery for esophageal cancer. It uses a special test called PEPTEST to track acid reflux after surgery and find out what affects it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had surgery to remove esophageal cancer.
- You can speak Mandarin.
- You are able to come to the hospital for follow-up visits.
- You do not have another serious life-threatening illness like leukemia or autoimmune disease.
- You do not have memory problems, thinking difficulties, or mental illness.
- You are willing to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 trial compares different “treatments before surgery” for people with esophageal (or esophagus-to-stomach) cancer. It aims to see which approach works better to control the cancer and improve outcomes after surgery.
This study looks at patients who came to Beijing Friendship Hospital with stomach acid issues (GERD). Researchers want to understand how treatments like medications or anti-reflux surgery work over time. By joining, you help them improve care for others with the same condition.
This trial looks at whether a personalized blood test can detect cancer returning after surgery for esophageal cancer. It tests people who had chemoradiotherapy before surgery and still had some cancer remaining in the removed tissue. The goal is to use the blood test to catch any remaining or returning cancer early.
This study checks whether a special test of the esophagus after meals can find the exact reason for ongoing reflux symptoms when proton pump pills (PPIs) don’t help. It may help doctors choose the right next treatment for people whose reflux symptoms keep coming back.
This study is looking for people newly diagnosed with esophageal cancer or cancer at the stomach-esophagus junction who are planning to have surgery. The goal is to see if certain noninvasive tests (like scans) can help predict how the disease will progress.
This study tests a new way to manage complications after esophageal cancer surgery using a special algorithm. The goal is to improve recovery and care for patients who have this surgery.
Hear when a new GASTROINTESTINAL NEOPLASMS trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.